CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Apotex Inc. et al. vs. Merck Sharp & Dohme Corp.

πŸ“‘ 5G SEP β€’ ETSI Declared

Explore the PTAB proceeding IPR2015-00419 filed by Apotex Inc. et al. on 2014-12-11. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2015-00419

Filing Date

2014-12-11

Accorded Filing Date

2014-12-11

Institution Decision Date

2015-06-25

Last Modified Date

2022-10-10

Proceeding Type

IPR

Termination Date

2015-06-25

Trial Status

Institution Denied

Parties & Counsel

Petitioner

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 08525870
Respondent Patent Number 5691336
Legal Expiration Date
2019-03-04 Expired (Term Ended)
Patent Term Adjustment (PTA) +1273 Days Awarded
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred
Respondent Inventor CONRAD DORN
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Decisions Rendered

1 Total

Proceeding Status

Institution Denied

Board Decisions & Rulings (1)

Institution Denied 2015-06-25
Decision - Denying Institution of Inter Partes Review
35 USC 314, 37 CFR 42.100, 37 CFR 42.108

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 3 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 1 proceeding
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (3): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (1 found):
U.S. Courts: 1
U.S. District Court 2014-07-09
1:14-cv-00905

Merck Sharp & Dohme Corp. v. Fresenius Kabi USA LLC

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Standard Essential Patent (SEP) & FRAND Intelligence

5G SEP β€’ ETSI Declared High-Probability SEP Action

Essential standard specifications, SSO declaration status, and FRAND antitrust defense evaluation

FRAND Encumbered
Essential Standard 4G / 5G LTE Generation: 5G
Standard Setting Org (SSO) ETSI / 3GPP Essential specification under ETSI / 3GPP governance
FRAND Commitment Committed Fair, Reasonable & Non-Discrim.
Known Patent Pools Avanci / Sisvel / Via Licensing Coverage Applicable Declarant: Sharp

Injunction Restrictions & FRAND Defense Leverage (CJEU Huawei v. ZTE Framework)

Permanent Injunction Restricted

Asserted by recognized SEP declarant. Under the CJEU Huawei v. ZTE test, injunctions are barred if the defendant qualifies as a willing licensee.

βœ“ Patentee bound by SSO IPR Policy (ETSI Annex 6 / IEEE Patent Policy).
βœ“ Right to demand global FRAND portfolio determination.
βœ“ Non-discrimination defense: check licensing terms offered to competing implementers.

Proceeding Documents

59
18

Decision Order Denying Petitioner's Request for Rehearing Paper

2015-10-27 FILING PARTY: BOARD
16

Petition Suggesting Reconsideration Paper

2015-07-24 FILING PARTY: PETITIONER
15

Request for Reconsideration Paper

2015-07-24 FILING PARTY: PETITIONER
1027

Ex parte Cao Exhibits

2015-07-24 FILING PARTY: PETITIONER
1028

Hale (1998) Exhibits

2015-07-24 FILING PARTY: PETITIONER

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc